dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Gastelurrutia, Paloma |
dc.contributor.author | Prat-Vidal, Cristina |
dc.contributor.author | Vives Armengol, Joaquim |
dc.contributor.author | Coll, Ruth |
dc.contributor.author | Bayes-Genis, Antoni |
dc.contributor.author | Gálvez-Montón, Carolina |
dc.date.accessioned | 2021-07-07T12:37:38Z |
dc.date.available | 2021-07-07T12:37:38Z |
dc.date.issued | 2021-02-04 |
dc.identifier.citation | Gastelurrutia P, Prat-Vidal C, Vives J, Coll R, Bayes-Genis A, Gálvez-Montón C. Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience. Front Cardiovasc Med. 2021 Feb 4;8:604434. |
dc.identifier.issn | 2297-055X |
dc.identifier.uri | https://hdl.handle.net/11351/6128 |
dc.description | Medicament de teràpia avançada; Medicament en investigació; Translacional (regulació) |
dc.description.sponsorship | This work was supported by the Spanish Cell Therapy Network (TerCel) [RD16/0011/0006 and RD16/0011/0028]; and CIBER Cardiovascular [CB16/11/00403] projects, as a part of the National R&D&I Plan, and was co-funded by the ISCIII-Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF); the Government of Catalonia: Agency for Management of University and Research Grants (AGAUR) [2017-SGR-483 and 2017-SGR-719], PERIS Program (Health Department) [SLT002/16/00234 and SLT002/16/00209] and CERCA Program; La Caixa Banking Foundation; grants from the Spanish Ministry of Science, Innovation and Universities (MICINN) [SAF2017-84324-C2-1-R]; Institute of Health Carlos III (ISCIII) [PI18/00256, PIC18/00014, ICI19/00039, and PI19/01788], and cofunded by European Union (ERDF/ESF) - A way to build Europe. This work has also been funded by the Sociedad Española de Cardiología and by the Call for Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine 2019 of Center for Regenerative Medicine of Barcelona (CMR[B]). The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Cardiovascular Medicine;8 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Medicina - Investigació - Espanya |
dc.subject | Medicina basada en l'evidència |
dc.subject | Medicaments - Desenvolupament |
dc.subject.mesh | Translational Medical Research |
dc.subject.mesh | Therapies, Investigational |
dc.subject.mesh | Spain |
dc.title | Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fcvm.2021.604434 |
dc.subject.decs | investigación médica traslacional |
dc.subject.decs | tratamientos en investigación |
dc.subject.decs | España |
dc.relation.publishversion | https://www.frontiersin.org/articles/10.3389/fcvm.2021.604434/full |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Gastelurrutia P, Prat-Vidal C] Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain. Insuficiencia Cardíaca y Regeneración Cardíaca Research Program, Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Spain. Centro de Investigación Biomédica en Red Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain. [Vives J] Servei de Teràpia Cel·lular, Banc de Sang i Teixits, Barcelona, Spain. Grup d’Enginyeria tissular musculoesquelètica, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Coll R] Servei de Teràpia Cel·lular, Banc de Sang i Teixits, Barcelona, Spain. [Bayes-Genis A] Insuficiencia Cardíaca y Regeneración Cardíaca Research Program, Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Spain. Centro de Investigación Biomédica en Red Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain. Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Gálvez-Montón C] Insuficiencia Cardíaca y Regeneración Cardíaca Research Program, Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Spain. Centro de Investigación Biomédica en Red Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain |
dc.identifier.pmid | 33614746 |
dc.identifier.wos | 000619000600001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0011%2F0028 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0011%2F0006 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CB16%2F11%2F00403 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/2017SGR483 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/2017SGR719 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/SLT002%2F16%2F00234 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/SLT002%2F16%2F00209 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/SAF2017-84324-C2-1-R |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F00256 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PIC18%2F00014 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/ICI19%2F00039 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01788 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |